Emeryville, California and Indianapolis, Indiana, USA
February 4, 2016
Dow AgroSciences, a wholly owned subsidiary of The Dow Chemical Company (NYSE: DOW), and Radiant Genomics are announcing a research and development (R&D) collaboration agreement to discover novel natural products for application in crop protection products. The collaboration combines the proprietary meta-genomic and engineering biology from Radiant with Dow AgroSciences’ industry leading natural products discovery and product development capabilties to deliver new products from naturally derived chemistries.
Dow AgroSciences is an industry leader in discovering and developing natural and semi-synthetic crop protection products. Spinosad and spinetoram are two market-leading insecticides in the spinosyns family, derived through fermentation, that meet farmers’ needs for insect control in many crops and geographies around the world.
“This collaboration will allow us to combine the expertise and capabilities within Dow AgroSciences with Radiant’s proprietary technologies to accelerate our industry-recognized natural products discovery program, building on our commitment to sustainable solutions,” said Daniel R. Kittle, vice president of Research and Development at Dow AgroSciences.
About the Company
Radiant Genomics, Inc. was founded in 2012 with the goal of integrating a range of novel technologies including large-scale sequencing, synthetic biology, bioinformatics, cloud computing, metabolic engineering, and high-throughput analytical chemistry to develop a robust industrial platform for natural product discovery, diversification, and production. Radiant Genomics utilizes this platform to develop products in numerous market categories including pharmaceuticals, agriculture, specialty chemicals, and nutraceuticals.
Topics
Species
